EquityNet Research Initiates Coverage on Huifeng Biopharmaceutical (OTCBB:HFGB)

LOS ANGELES – Feb. 10, 2010 — EquityNet Research, an independent West Coast equity research firm, announced today that it has initiated coverage on Huifeng Bio-Pharmaceutical Technology, Inc. (OTCBB: HFGB).
A full copy of the report and disclosure requirements are available at EquityNet Research’s Web site: www.equitynet.net.
Huifeng develops, produces and sells [...]